Drug Type Small molecule drug |
Synonyms MK-8831 |
Target |
Action inhibitors |
Mechanism NS3 inhibitors(Hepatitis C virus (HCV) nonstructural protein 3 inhibitors), NS3/NS4A inhibitors(Hepatitis C virus serine protease, NS3/NS4A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC40H50F3N5O9S |
InChIKeyGBJKXZJNFVRHCK-XPTVTBSVSA-N |
CAS Registry1565770-83-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Preclinical | United States | 23 Dec 2015 |